Zydus Lifesciences Limited (ZYDUSLIFE.BO)
INR 859.55
(2.64%)
INR 859.55
(2.64%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 43.17 Billion INR | 67.75% |
| 2023 | 74.64 Billion INR | 14.27% |
| 2022 | 65.32 Billion INR | 3.41% |
| 2021 | 63.16 Billion INR | -4.38% |
| 2020 | 66.05 Billion INR | 20.84% |
| 2019 | 54.66 Billion INR | 10.7% |
| 2018 | 49.38 Billion INR | 22.53% |
| 2017 | 40.3 Billion INR | -1.84% |
| 2016 | 41.05 Billion INR | 6.57% |
| 2015 | 38.52 Billion INR | 13.57% |
| 2014 | 33.92 Billion INR | 13.15% |
| 2013 | 29.98 Billion INR | 18.16% |
| 2012 | 25.37 Billion INR | 22.17% |
| 2011 | 20.76 Billion INR | 21.81% |
| 2010 | 17.05 Billion INR | 17.07% |
| 2009 | 14.56 Billion INR | 31.92% |
| 2008 | 11.04 Billion INR | 29.57% |
| 2007 | 8.52 Billion INR | 28.5% |
| 2006 | 6.63 Billion INR | 13.43% |
| 2005 | 5.84 Billion INR | 14.54% |
| 2004 | 5.1 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 23.35 Billion INR | 17.44% |
| 2024 Q2 | 19.05 Billion INR | -5.96% |
| 2024 FY | 82.54 Billion INR | 10.59% |
| 2024 Q3 | 19.88 Billion INR | 4.36% |
| 2024 Q1 | 20.25 Billion INR | -4.13% |
| 2023 Q2 | 18.43 Billion INR | -1.38% |
| 2023 FY | 74.64 Billion INR | 14.27% |
| 2023 Q4 | 21.13 Billion INR | 6.71% |
| 2023 Q3 | 19.8 Billion INR | 7.39% |
| 2023 Q1 | 18.69 Billion INR | 26.06% |
| 2022 Q1 | 17.4 Billion INR | 18.75% |
| 2022 FY | 65.32 Billion INR | 3.41% |
| 2022 Q4 | 14.83 Billion INR | -8.52% |
| 2022 Q3 | 16.21 Billion INR | 2.65% |
| 2022 Q2 | 15.79 Billion INR | -9.25% |
| 2021 Q2 | 17.18 Billion INR | 5.66% |
| 2021 FY | 63.16 Billion INR | -4.38% |
| 2021 Q1 | 16.26 Billion INR | 35.78% |
| 2021 Q4 | 14.65 Billion INR | -18.58% |
| 2021 Q3 | 17.99 Billion INR | 4.72% |
| 2020 Q2 | 16.24 Billion INR | -7.16% |
| 2020 Q1 | 17.49 Billion INR | 58.6% |
| 2020 FY | 66.05 Billion INR | 20.84% |
| 2020 Q4 | 11.98 Billion INR | -32.18% |
| 2020 Q3 | 17.66 Billion INR | 8.75% |
| 2019 Q2 | 14.29 Billion INR | 1.79% |
| 2019 Q4 | 11.03 Billion INR | -28.34% |
| 2019 Q1 | 14.03 Billion INR | -2.54% |
| 2019 Q3 | 15.39 Billion INR | 7.73% |
| 2019 FY | 54.66 Billion INR | 10.7% |
| 2018 Q1 | 12.05 Billion INR | 1.03% |
| 2018 Q3 | 14.29 Billion INR | 2.48% |
| 2018 Q4 | 14.4 Billion INR | 0.74% |
| 2018 FY | 49.38 Billion INR | 22.53% |
| 2018 Q2 | 13.95 Billion INR | 15.74% |
| 2017 Q1 | 10.73 Billion INR | -0.85% |
| 2017 FY | 40.3 Billion INR | -1.84% |
| 2017 Q4 | 11.93 Billion INR | 8.75% |
| 2017 Q3 | 10.97 Billion INR | 1.17% |
| 2017 Q2 | 10.84 Billion INR | 1.03% |
| 2016 Q2 | 10.34 Billion INR | -1.61% |
| 2016 FY | 41.05 Billion INR | 6.57% |
| 2016 Q3 | 10.48 Billion INR | 1.33% |
| 2016 Q1 | 10.51 Billion INR | 8.68% |
| 2016 Q4 | 10.82 Billion INR | 3.29% |
| 2015 Q2 | 9.23 Billion INR | 0.61% |
| 2015 Q3 | 10.43 Billion INR | 13.01% |
| 2015 Q4 | 9.67 Billion INR | -7.33% |
| 2015 Q1 | 9.17 Billion INR | 14.24% |
| 2015 FY | 38.52 Billion INR | 13.57% |
| 2014 Q3 | 8.92 Billion INR | 5.1% |
| 2014 FY | 33.92 Billion INR | 13.15% |
| 2014 Q4 | 8.03 Billion INR | -10.0% |
| 2014 Q2 | 8.49 Billion INR | 0.36% |
| 2014 Q1 | 8.46 Billion INR | 45.67% |
| 2013 Q1 | 7.31 Billion INR | 61.47% |
| 2013 Q2 | 7.57 Billion INR | 3.57% |
| 2013 Q3 | 8.24 Billion INR | 8.8% |
| 2013 FY | 29.98 Billion INR | 18.16% |
| 2013 Q4 | 5.81 Billion INR | -29.52% |
| 2012 Q2 | 6.46 Billion INR | 0.0% |
| 2012 Q3 | 7.16 Billion INR | 10.81% |
| 2012 Q4 | 4.53 Billion INR | -36.73% |
| 2012 FY | 25.37 Billion INR | 22.17% |
| 2011 FY | 20.76 Billion INR | 21.81% |
| 2010 FY | 17.05 Billion INR | 17.07% |
| 2009 FY | 14.56 Billion INR | 31.92% |
| 2008 FY | 11.04 Billion INR | 29.57% |
| 2007 FY | 8.52 Billion INR | 28.5% |
| 2006 FY | 6.63 Billion INR | 13.43% |
| 2005 FY | 5.84 Billion INR | 14.54% |
| 2004 FY | 5.1 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -172.053% |
| Aurobindo Pharma Limited | 39.23 Billion INR | -10.039% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -270.889% |
| Granules India Limited | 7.18 Billion INR | -501.111% |
| Indoco Remedies Limited | 4.74 Billion INR | -809.161% |
| Achyut Healthcare Limited | 1.6 Million INR | -2683181.541% |
| Ajanta Pharma Limited | 30.46 Billion INR | -41.727% |
| Alkem Laboratories Limited | 32.83 Billion INR | -31.488% |
| Alpa Laboratories Limited | 156.14 Million INR | -27549.587% |
| Brooks Laboratories Limited | 51.18 Million INR | -84257.171% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -1560.283% |
| Bajaj HealthCare Limited | 985.34 Million INR | -4281.613% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -2942.089% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 54.97% |
| Eris Lifesciences Limited | 4.94 Billion INR | -773.448% |
| FDC Limited | 5.34 Billion INR | -707.213% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 36.099% |
| Gufic Biosciences Limited | 1.07 Billion INR | -3906.083% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -1932.498% |
| Ipca Laboratories Limited | 13.91 Billion INR | -210.272% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -5482.291% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -93439.301% |
| Lasa Supergenerics Limited | 291.17 Million INR | -14727.56% |
| Laurus Labs Limited | 3.01 Billion INR | -1333.971% |
| Lupin Limited | 95.67 Billion INR | 54.874% |
| Mankind Pharma Limited | 23.15 Billion INR | -86.475% |
| Medicamen Biotech Limited | 335.16 Million INR | -12781.34% |
| Medico Remedies Limited | 161.84 Million INR | -26576.306% |
| Megasoft Limited | 49.52 Million INR | -87070.895% |
| NATCO Pharma Limited | 10.05 Billion INR | -329.25% |
| Piramal Pharma Limited | 19.91 Billion INR | -116.802% |
| RPG Life Sciences Limited | 1.63 Billion INR | -2539.804% |
| Sigachi Industries Limited | 579.88 Million INR | -7345.244% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 71.998% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -2977.726% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -4481.287% |
| Unichem Laboratories Limited | 6.72 Billion INR | -541.91% |
| Wanbury Limited | 1.16 Billion INR | -3618.925% |
| Windlas Biotech Limited | 1 Billion INR | -4189.476% |
| ZIM Laboratories Limited | 1.01 Billion INR | -4161.75% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -1303.211% |
| Divi's Laboratories Limited | 14.17 Billion INR | -204.686% |
| Hester Biosciences Limited | 908.84 Million INR | -4650.451% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -1341.343% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -3828.523% |
| Bal Pharma Limited | 389.89 Million INR | -10973.38% |
| Strides Pharma Science Limited | 9.16 Billion INR | -371.214% |
| Venus Remedies Limited | 1.91 Billion INR | -2153.006% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -1304.307% |
| Nectar Lifesciences Limited | 625.55 Million INR | -6801.766% |
| Shilpa Medicare Limited | 2.18 Billion INR | -1879.924% |
| Aarti Drugs Limited | 1.16 Billion INR | -3598.054% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -3829.195% |
| Suven Life Sciences Limited | 109.75 Million INR | -39238.497% |
| Ind-Swift Limited | 946.56 Million INR | -4461.114% |
| Valiant Laboratories Limited | 36.28 Million INR | -118872.691% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | -412.933% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | -842.726% |
| Themis Medicare Limited | 782.85 Million INR | -5414.942% |
| Hikal Limited | 2.48 Billion INR | -1636.448% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -101.54% |
| Sequent Scientific Limited | 2.9 Billion INR | -1387.83% |
| Novartis India Limited | 470.1 Million INR | -9084.003% |
| Wockhardt Limited | 6.4 Billion INR | -574.594% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -198.699% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -266246.71% |
| Neuland Laboratories Limited | 2.92 Billion INR | -1373.643% |
| Morepen Laboratories Limited | 1.98 Billion INR | -2072.331% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -10368.277% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -6285.298% |